Thermo Fisher Scientific | TMO - Current Assets



Thermo Fisher Scientific reported $24.58B in Current Assets for its fiscal quarter ending in June of 2025.


Current Assets Change Date
Abbott USD 24.47B 1.32B Jun/2025
Agilent USD 4.25B 45M Jul/2025
Becton, Dickinson and Co. USD 9B 331M Jun/2025
Bio Techne USD 608.3M 18.94M Jun/2025
Bio-Rad Laboratories USD 2.81B 225.5M Jun/2025
Boston Scientific USD 7.34B 415M Mar/2025
Bruker USD 2.16B 51.2M Jun/2025
Charles River Laboratories USD 1.47B 36.5M Jun/2025
Danaher USD 11B 1.47B Jun/2025
Dentsply International USD 1.97B 12M Jun/2025
Edwards Lifesciences USD 6.21B 72.7M Mar/2025
Exact Sciences USD 1.51B 137.52M Jun/2025
General Electric Aerospace USD 37.8B 226M Jun/2025
Henry Schein USD 4.24B 206M Jun/2025
Hologic USD 3.42B 212.7M Jun/2025
Illumina USD 2.64B 32M Jun/2025
Intuitive Surgical USD 12.47B 592.4M Jun/2025
IQVIA Holdings USD 6.35B 434M Jun/2025
Laboratory Of America USD 4.09B 297.5M Jun/2025
Medtronic USD 23.81B 1.3B Apr/2025
Mettler Toledo International USD 1.24B 79.67M Jun/2025
Myriad Genetics USD 287.2M 10.8M Mar/2025
Olympus JPY 684.04B 4.6B Jun/2025
Quest Diagnostics USD 2.2B 123M Jun/2025
Repligen USD 1.03B 33.58M Mar/2025
Revvity USD 2.24B 81.76M Jun/2025
Stryker USD 13B 19M Jun/2025
Thermo Fisher Scientific USD 24.58B 1.21B Jun/2025
Veracyte USD 414.68M 31.53M Jun/2025
Waters USD 1.78B 42.24M Jun/2025
Zimmer Biomet Holdings USD 5.05B 536.3M Jun/2025